HYPR Hyperfine Inc Projected Price to Earnings

Corporate company logo of Hyperfine Medical (HYPR)

The market trend for Hyperfine, Inc. (HYPR) shown on this price chart demonstrates the 0.00 indicator. Hyperfine, Inc. (HYPR) develops high-tech devices for deep health analysis. The company generates revenue through the sale of portable MRI scanners for intensive care units and mobile centers, as well as via cloud software. The business relies on an autonomous development cycle, making it resilient to global crises and a reliable defensive asset.

HYPR - hyperfine.io Market Cap to Projected Earnings over the range 07/04/2022 - 11/11/2026

Financial and market metric breakdowns for Hyperfine Medical (HYPR)

- stock value and consensus price forecast:
Price Chart Hyperfine|HYPR - Analyst Median Target
- market capitalization data:
Market Valuation Hyperfine Inc|HYPR - Aggregate Business Value
- issuer book value statistics:
Book Value per Share Hyperfine|HYPR - Book Valuation of Business|Market Capitalization to Book Value Ratio hyperfine.io|HYPR - Cumulative Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Hyperfine, Inc.|HYPR - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Hyperfine, Inc.|HYPR - Company Total Debt|Debts to Book Capitalization Hyperfine Inc|HYPR - Long-Term Debt|Company Short-Term Debts Hyperfine|Quick Ratio hyperfine.io
- earnings and market ratios statistics:
HYPR - Net Financial Result|Projected Future Earnings Hyperfine, Inc.|HYPR - Price to Earnings Ratio|Forward P/E Multiple Hyperfine Corp|HYPR - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Hyperfine Inc|HYPR - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Hyperfine|HYPR - Earnings per share for the trailing year|Quarterly EPS earnings growth hyperfine.io|HYPR - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Hyperfine, Inc.
Fundamental company analysis:Hyperfine
Product sample of Hyperfine, Inc.

Evaluating future earnings is critical for identifying the fundamental drivers of stability for Hyperfine, Inc. (HYPR). This indicator compares the current market price with projected net income, accounting for solvency risks and debt load. The trend of the company's expected P/E ratio allows for the rapid identification of whether the asset is undervalued or overpriced. A declining ratio may signal liquidity issues, which is particularly significant for scaling sales of Swoop portable MRI scanners featuring AI reconstruction.

Competitors of Hyperfine, Inc. (HYPR)

Future Price to Earnings Abbott (ABT)|Market Cap to Projected Earnings Thermo Fisher Scientific Inc.|GE Healthcare Corp - Projected Price to Earnings|Market Cap to Future Earnings Ratio MTD (Mettler Toledo Inc)|Waters Corporation - Forward P/E Multiple|Market Cap to Projected Earnings bio-techne.com TECH|BRKR: Forward P/E Multiple|Projected Price to Earnings Azenta Inc|Projected Price to Earnings VREX|SMLR: Future Price to Earnings Multiple|Future Price to Earnings Butterfly Network, Inc. (BFLY)|Projected Price to Earnings mesalabs.com MLAB|Forward P/E Multiple QSI (Quantum-Si Incorporated)|Nano-X Imaging (NNOX) - Projected Price to Earnings Ratio|Quanterix Corp - Forward P/E Multiple|MASS (908 Devices Corporation) - Price to Future Earnings Ratio|CV: Forward P/E Multiple|MXCT - Market Cap to Projected Earnings|RPID (Rapid Micro Biosystems Inc.) - Forward P/E Multiple|Projected Price to Earnings Seer Inc (SEER)|Forward P/E Multiple FONR|Forward P/E Multiple daxor.com (DXR)|Future Price to Earnings Spectral AI MDAI|organovo.com - Future Price to Earnings|ACON: Projected Price to Earnings|Future Price to Earnings Multiple AKYA (Akoya Biosciences)|THMO: Forward P/E Multiple|Projected Price to Earnings Ratio Talis Biomedical Corporation (TLIS)|Future Price to Earnings T2 Biosystems, Inc.